Total Payments
$623,496
2024 Payments
$1,159
Companies
56
Transactions
1,828
Medicare Patients
38,309
Medicare Billing
$3.0M
Payment Breakdown by Category
Other$523,864 (84.0%)
Travel$41,462 (6.6%)
Consulting$28,618 (4.6%)
Food & Beverage$28,573 (4.6%)
Education$859.58 (0.1%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $523,864 | 346 | 84.0% |
| Travel and Lodging | $41,462 | 296 | 6.6% |
| Consulting Fee | $28,618 | 12 | 4.6% |
| Food and Beverage | $28,573 | 1,138 | 4.6% |
| Education | $859.58 | 34 | 0.1% |
| Gift | $118.80 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $229,317 | 568 | $0 (2024) |
| Novo Nordisk Inc | $191,484 | 328 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $102,468 | 216 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $42,466 | 111 | $0 (2024) |
| MannKind Corporation | $37,924 | 108 | $0 (2023) |
| Abbott Laboratories | $11,218 | 21 | $0 (2018) |
| Amgen Inc. | $1,534 | 94 | $0 (2024) |
| Corcept Therapeutics | $754.11 | 30 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $605.03 | 27 | $0 (2024) |
| Dexcom, Inc. | $564.06 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,159 | 46 | Xeris Pharmaceuticals, Inc. ($308.03) |
| 2023 | $7,600 | 81 | MannKind Corporation ($5,793) |
| 2022 | $74,003 | 183 | Novo Nordisk Inc ($46,853) |
| 2021 | $61,742 | 225 | Novo Nordisk Inc ($24,872) |
| 2020 | $66,373 | 204 | Novo Nordisk Inc ($22,558) |
| 2019 | $108,157 | 314 | Lilly USA, LLC ($61,824) |
| 2018 | $149,090 | 396 | Novo Nordisk Inc ($58,806) |
| 2017 | $155,373 | 379 | Lilly USA, LLC ($77,917) |
All Payment Transactions
1,828 individual payment records from CMS Open Payments — Page 1 of 74
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Automated insulin delivery system | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Automated insulin delivery system | ||||||
| 11/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: LIVER DISEASE | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/10/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $22.03 | General |
| 09/19/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: DIABETES | ||||||
| 08/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Automated insulin delivery system | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 5,193 | 16,562 | $965,958 | $411,998 |
| 2022 | 46 | 10,018 | 48,240 | $2.0M | $880,364 |
| 2021 | 50 | 11,416 | 45,715 | $2.0M | $875,548 |
| 2020 | 44 | 11,682 | 42,422 | $2.0M | $813,368 |
Total Patients
38,309
Total Services
152,939
Medicare Billing
$3.0M
Procedure Codes
175
All Medicare Procedures & Services
175 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 692 | 2,634 | $194,916 | $121,918 | 62.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 759 | 1,247 | $187,210 | $95,854 | 51.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 137 | 758 | $75,800 | $25,816 | 34.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 137 | 758 | $84,896 | $25,123 | 29.6% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 96 | 141 | $21,150 | $14,148 | 66.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 190 | 377 | $18,850 | $13,480 | 71.5% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 116 | 116 | $32,480 | $12,857 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 89 | 98 | $20,090 | $12,728 | 63.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 139 | 148 | $34,040 | $10,898 | 32.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 120 | 120 | $29,280 | $9,574 | 32.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 153 | 154 | $27,720 | $8,856 | 31.9% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 65 | 80 | $28,000 | $7,683 | 27.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 145 | 299 | $53,820 | $6,916 | 12.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 525 | 723 | $7,230 | $6,051 | 83.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 155 | 156 | $42,900 | $5,569 | 13.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 298 | 311 | $10,574 | $5,070 | 47.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 164 | 165 | $9,900 | $4,706 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $8,570 | $3,637 | 42.4% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 249 | 261 | $7,308 | $3,603 | 49.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 265 | 278 | $11,676 | $2,624 | 22.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 248 | 260 | $4,680 | $2,281 | 48.7% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 32 | 33 | $5,280 | $1,969 | 37.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 41 | 41 | $8,200 | $1,648 | 20.1% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 42 | 49 | $4,214 | $1,462 | 34.7% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 41 | 205 | $20,500 | $1,283 | 6.3% |
About Dr. Ray Vaughters, MD
Dr. Ray Vaughters, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Aiken, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457327587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ray Vaughters, MD has received a total of $623,496 in payments from pharmaceutical and medical device companies, with $1,159 received in 2024. These payments were reported across 1,828 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($523,864).
As a Medicare-enrolled provider, Vaughters has provided services to 38,309 Medicare beneficiaries, totaling 152,939 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Aiken, SC
- Active Since 02/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1457327587
Products in Payments
- TRULICITY (Drug) $202,671
- FARXIGA (Drug) $97,574
- Ozempic (Drug) $79,985
- AFREZZA (Drug) $37,924
- Tresiba (Drug) $31,709
- SOLIQUA (Drug) $27,639
- Rybelsus (Drug) $26,700
- Victoza (Drug) $23,231
- RYBELSUS (Drug) $16,456
- MOUNJARO (Drug) $15,972
- TOUJEO (Drug) $13,465
- FreeStyle Libre Pro (Device) $9,737
- BYDUREON (Drug) $4,692
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $1,408
- SOLIQUA 100/33 (Drug) $829.08
- Korlym (Drug) $754.11
- Repatha (Biological) $666.91
- Vascepa (Drug) $541.14
- EVENITY (Biological) $474.07
- JARDIANCE (Drug) $416.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.